PBV Insights
Log In Get Started
Menu
Deals & Cases
15 Mar 2026

White & Case Advises Hayfin on €550M Unitranche Refinancing for Juvisé Pharmaceuticals

"White & Case LLP advised Hayfin Capital Management, acting as sole bondholder, on a €550 million unitranche financing for French pharmaceutical company Juvisé Pharmaceuticals—€400 million to refinance existing debt and €150 million as a new facility for future acquisitions. The White & Case Paris team was led by partner Samir Berlat, assisted by Martin Poirier and Imane Lazraq. Juvisé was advised by Latham & Watkins."

White & Case LLP advised Hayfin Capital Management (acting as sole bondholder), and Latham & Watkins advised Juvisé Pharmaceuticals. The transaction comprised a €550 million unitranche financing for Juvisé Pharmaceuticals, refinancing €400 million of existing debt and providing a new €150 million facility for future acquisitions. Lawyers named in the press release: White & Case’s Paris team was led by Samir Berlat (partner, financing) and was assisted by Martin Poirier and Imane Lazraq (associates, financing). No individual lawyers from Latham & Watkins were specified in the press release.
Read the full story

Register for free to access daily news.

Register Free
Already registered? Login
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.